US 11110093
Sustained release small molecule drug formulation
granted A61KA61K31/341A61K31/519
Quick answer
US patent 11110093 (Sustained release small molecule drug formulation) held by Indivior UK Limited expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Indivior UK Limited
- Grant date
- Tue Sep 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/341, A61K31/519, A61K47/10, A61K47/14